{"id":"https://openalex.org/W3131642323","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ps10-21","title":"Abstract PS10-21: Identifying efficacy of targeted HER2 antibodies in sensitization of HER2 positive breast cancer to fractionated radiation","display_name":"Abstract PS10-21: Identifying efficacy of targeted HER2 antibodies in sensitization of HER2 positive breast cancer to fractionated radiation","publication_year":2021,"publication_date":"2021-02-15","ids":{"openalex":"https://openalex.org/W3131642323","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ps10-21","mag":"3131642323"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs20-ps10-21","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ps10-21","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs20-ps10-21","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002504233","display_name":"Patrick N. Song","orcid":"https://orcid.org/0000-0002-1545-0886","observed_orcids":["https://orcid.org/0000-0002-1545-0886"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick N. Song","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023317702","display_name":"Yun L\u00fc","orcid":"https://orcid.org/0000-0002-4785-3401","observed_orcids":["https://orcid.org/0000-0002-4785-3401"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yun Lu","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014303592","display_name":"Tiara S. Napier","orcid":"https://orcid.org/0000-0003-3574-6323","observed_orcids":["https://orcid.org/0000-0003-3574-6323"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tiara Napier","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008120184","display_name":"Sharon L. Samuel","orcid":"https://orcid.org/0000-0002-5211-0661","observed_orcids":["https://orcid.org/0000-0002-5211-0661"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharon Samuel","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068520761","display_name":"Katherine A. Heinzman","orcid":"https://orcid.org/0009-0007-5768-123X","observed_orcids":["https://orcid.org/0009-0007-5768-123X"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine Heinzman","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075304112","display_name":"Suzanne E. Lapi","orcid":"https://orcid.org/0000-0003-0090-0191","observed_orcids":["https://orcid.org/0000-0003-0090-0191"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suzanne E. Lapi","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027284323","display_name":"Anna G. Sorace","orcid":"https://orcid.org/0000-0002-3640-3966","observed_orcids":["https://orcid.org/0000-0002-3640-3966"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna G. Sorace","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I32389192"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"81","issue":"4_Supplement","first_page":"PS10","last_page":"21"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.3752000033855438,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.3752000033855438,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.3149000108242035,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.07029999792575836,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9950000047683716},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9089999794960022},{"id":"https://openalex.org/keywords/fractionated-radiotherapy","display_name":"fractionated radiotherapy","score":0.8579999804496765},{"id":"https://openalex.org/keywords/radiosensitization","display_name":"radiosensitization","score":0.8289999961853027},{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.9290000200271606},{"id":"https://openalex.org/keywords/molecular-imaging","display_name":"molecular imaging","score":0.6690000295639038},{"id":"https://openalex.org/keywords/treatment-synergy","display_name":"treatment synergy","score":0.7730000019073486},{"id":"https://openalex.org/keywords/dna-double-strand-breaks","display_name":"DNA double-strand breaks","score":0.8119999766349792},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8399999737739563},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.48399999737739563},{"id":"https://openalex.org/keywords/tumor-oxygenation","display_name":"tumor oxygenation","score":0.7070000171661377},{"id":"https://openalex.org/keywords/cell-death","display_name":"cell death","score":0.3479999899864197}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7878848314285278},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6813715696334839},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.6595578193664551},{"id":"https://openalex.org/C191560914","wikidata":"https://www.wikidata.org/wiki/Q7390592","display_name":"SKBR3","level":5,"score":0.5907900333404541},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.5884859561920166},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5271379947662354},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.413277804851532},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.39247509837150574},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3730822801589966},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27900516986846924},{"id":"https://openalex.org/C2994423619","wikidata":"https://www.wikidata.org/wiki/Q9103","display_name":"Human breast","level":4,"score":0.06281912326812744}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs20-ps10-21","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ps10-21","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs20-ps10-21","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3178262059","https://openalex.org/W3082861623","https://openalex.org/W4213281771","https://openalex.org/W3013926224","https://openalex.org/W2511531062","https://openalex.org/W2500127212","https://openalex.org/W2030009220","https://openalex.org/W2973188102","https://openalex.org/W2520933115","https://openalex.org/W2396142337"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Tumor":[2],"hypoxia":[3],"contributes":[4],"to":[5,22,67,87,103,242,262,299,328,431,510,527,532,543,593],"intra-tumoral":[6],"heterogeneity":[7],"and":[8,26,83,123,135,140,149,157,160,179,181,193,202,204,213,227,256,267,363,399,466,492,520,535,556],"decreases":[9],"efficacy":[10,515,581],"of":[11,30,63,91,130,250,254,370,384,441,455,473,483,490,500,516,582,588,599],"cytotoxic":[12,109],"therapy.":[13,110,501,546],"Fractionated":[14],"radiation":[15,47,137,159,206,282,301,330,348,365,379,401,418,450,468,494,512,595],"therapy":[16,32,48],"has":[17,101,525],"emerged":[18],"as":[19],"an":[20],"alternative":[21],"single":[23,216,277,340,415,447],"dose":[24],"radiation,":[25],"is":[27,49,66],"a":[28,257,367,381,403,420,452,470],"component":[29],"standard-of-care":[31],"for":[33,142,162,237,247,264,554],"patients":[34],"with":[35,72,127,154,195,325,361,377,397,414,446,463,507],"unresectable":[36],"human":[37],"epidermal":[38],"growth":[39],"factor":[40],"receptor":[41],"2":[42,212],"(HER2+)":[43],"breast":[44,99,117,504,591],"cancer.":[45],"Because":[46],"dependent":[50],"on":[51,199,209,223,312,388],"tissue":[52],"oxygenation,":[53],"therapies":[54,534],"that":[55],"increase":[56,104],"oxygenation":[57,82],"could":[58],"radio-sensitize":[59],"tumors.":[60],"The":[61],"goal":[62],"this":[64],"study":[65],"investigate":[68],"if":[69],"molecular":[70],"imaging":[71,85,220,231,524],"[18F]-fluoromisonidazole":[73],"(FMISO)-PET":[74],"can":[75],"quantify":[76],"anti-HER2":[77],"therapy-induced":[78],"changes":[79,246,538],"in":[80,97,113,172,315,408,425,486,518,521,529,539,586],"tumor":[81,244,409,426,453,471,541],"utilize":[84],"metrics":[86],"enhance":[88],"the":[89,230,540,550,600],"effectiveness":[90,106],"fractionated":[92,136,158,205,281,300,329,347,364,378,400,417,449,467,493,511,594],"radiation.":[93],"Improving":[94],"treatment":[95,265,488],"synergy":[96,266,489],"HER2+":[98,116,145,175,182,503],"cancer":[100,118,146,505,592],"potential":[102,526],"therapeutic":[105],"without":[107],"increasing":[108],"Methods:":[111],"For":[112,171],"vitro":[114,272,519],"studies,":[115,174],"cells":[119,147,323],"(BT474,":[120],"SKBR3,":[121],"MDA-MB-361":[122,316,322,358,394,443],"MDA-MB-453)":[124],"were":[125,151,189,234],"treated":[126,153,194,283,324,360,376,396,413,445,462,506],"various":[128],"sequencing":[129],"combination":[131,155,464,533,545],"trastuzumab":[132,156,196,279,297,326,342,362,398,465,491,508],"(1":[133],"\u00b5g/mL)":[134],"(6/3":[138,207],"Gy)":[139,208],"assessed":[141],"cell":[143,176,273,293,307],"death.":[144],"(BT474":[148,178],"MDA-MB-361)":[150,180],"also":[152],"analyzed":[161],"DNA":[163],"double":[164],"strand":[165],"breaks":[166],"(DSB)":[167],"through":[168],"flow":[169],"cytometry.":[170],"vivo":[173,487,530],"line":[177],"patient":[183],"derived":[184],"xenograft":[185],"(BCM":[186],"3472)":[187],"tumors":[188,233,359,375,395,412,444,461],"engrafted":[190],"into":[191],"mice":[192],"(4":[197],"mg/kg)":[198],"days":[200,210,438,497],"0":[201,430],"3":[203,214,226],"1,":[211],"(or":[215],"agent":[217,278,341,416,448],"control).":[218],"[18F]-FMISO-PET":[219,523],"was":[221,260],"conducted":[222],"day":[224,313,389,429,432],"0,":[225],"7.":[228],"At":[229],"endpoint,":[232],"either":[235],"extracted":[236],"biological":[238],"validation":[239],"or":[240,280,289,346],"continued":[241],"measure":[243],"size":[245],"longitudinal":[248],"assessment":[249],"response.":[251],"Bliss":[252,481],"test":[253,482],"independence":[255,484],"non-parametric":[258],"T-test":[259],"used":[261],"assess":[263],"significance,":[268],"respectively.":[269],"Results:":[270],"In":[271,356],"death":[274,294,308],"assay":[275],"revealed":[276],"groups":[284,302,349],"exhibited":[285,303,331],"15.2%":[286],"\u00b1":[287,291,305,333,344,351,372,386,405,422,457,475],"6.5%":[288],"53.6%":[290],"9%":[292],"respectively,":[295],"while":[296,374,411],"prior":[298,327,509],"72.5%":[304],"2.5%":[306],"(p":[309,353,391,434,478],"=":[310,354,392,435],"0.01)":[311],"7":[314,390,433],"cells.":[317],"Flow":[318],"cytometry":[319],"analysis":[320],"showed":[321],"62.4%":[332],"8.7%":[334],"DSB,":[335],"which":[336],"significantly":[337],"increased":[338],"from":[339,428],"(0.74%":[343],"0.39%)":[345],"(37.3%":[350],"7.3%)":[352],"0.01).":[355,480],"vivo,":[357],"had":[366,380,451,469],"[18F]-FMISO":[368,382],"SUVmean":[369,383],"0.20":[371],"0.09,":[373],"0.31":[385],"0.06":[387],"0.05).":[393],"experienced":[402,419],"26.1%":[404],"16.8%":[406],"decrease":[407,424],"volume,":[410],"10.4%":[421],"2.8%":[423],"volume":[427,454,472],"0.11).":[436],"30":[437],"after":[439,498],"start":[440,499],"therapy,":[442],"471.8":[456],"120":[458],"mm3,":[459],"whereas":[460],"116":[474],"38":[476],"mm3":[477],"<":[479],"confirmed":[485],"starting":[495],"14":[496],"Conclusion:":[502],"synergistically":[513],"increases":[514],"radiotherapy":[517],"vivo.":[522],"identify":[528],"response":[531],"better":[536],"understand":[537],"microenvironment":[542],"guide":[544],"Acknowledgements:":[547],"We":[548],"thank":[549],"American":[551],"Cancer":[552,605,617],"Society":[553],"RSG-18-006-01-CCE":[555],"NIH":[557],"NCI":[558],"R01":[559],"CA240589.":[560],"Citation":[561],"Format:":[562],"Patrick":[563],"N.":[564],"Song,":[565],"Yun":[566],"Lu,":[567],"Tiara":[568],"Napier,":[569],"Sharon":[570],"Samuel,":[571],"Katherine":[572],"Heinzman,":[573],"Suzanne":[574],"E.":[575],"Lapi,":[576],"Anna":[577],"G.":[578],"Sorace.":[579],"Identifying":[580],"targeted":[583],"HER2":[584,589],"antibodies":[585],"sensitization":[587],"positive":[590],"[abstract].":[596],"In:":[597],"Proceedings":[598],"2020":[601,608],"San":[602,611],"Antonio":[603],"Breast":[604],"Virtual":[606],"Symposium;":[607],"Dec":[609],"8-11;":[610],"Antonio,":[612],"TX.":[613],"Philadelphia":[614],"(PA):":[615],"AACR;":[616],"Res":[618],"2021;81(4":[619],"Suppl):Abstract":[620],"nr":[621],"PS10-21.":[622]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2021-03-01T00:00:00"}